IntelliProve Competitive Intelligence & Landscape

IntelliProve is a Belgium-based HealthTech company founded in 2021 that specializes in innovative digital healthcare solutions. Its core technology involves a contactless facial analysis system that accurately measures various health parameters within seconds, utilizing optical measurements and AI-driven signal processing (Exa). The company's primary product is a software-driven health assessment platform that enables healthcare providers, wellness apps, and digital health platforms to deliver real-time, personalized health insights without the need for external sensors or hardware (IntelliProve).

Targeting the digital health market, IntelliProve aims to enhance user engagement and improve health outcomes through hyper-personalized biomarker analysis, focusing on both physiological and mental health parameters. Its solutions are designed to be integrated seamlessly into existing health and well-being platforms, making health monitoring faster, more accessible, and remote-friendly (Exa).

Headquartered in Ghent, Belgium, the company employs around 15 staff members and has experienced significant growth, with a focus on research, development, and partnerships with academic institutions and healthcare organizations. IntelliProve’s mission is to transform health monitoring by providing scientifically validated, AI-powered facial analysis technology that can save lives and advance personalized medicine (Exa, BounceWatch). Its value proposition centers on delivering fast, contactless, and scalable health insights that empower both healthcare providers and consumers.

As of April 2026, detailed information about IntelliProve's specific product and pricing plans is limited in the available sources. However, it is clear that IntelliProve offers a health assessment solution through facial analysis, utilizing clinically validated biomarker data that can be remotely captured via any camera (IntelliProve). The platform is designed to be quickly integrated, with most teams able to set up the system in less than one day, and it supports customization, white labeling, and biomarker selection (IntelliProve FAQ).

Recent funding rounds and partnerships highlight its active development and deployment in health monitoring, with investments totaling €1.25 million and collaborations with institutions like TU Delft to enhance its AI-driven biometric analysis (Tech.eu, IntelliProve News). While specific tiered pricing, free vs paid features, or recent pricing changes are not explicitly detailed in the search results, the platform emphasizes quick onboarding, customization, and secure integration, indicating a flexible, enterprise-oriented pricing model likely tailored to client needs.

Recent insights into IntelliProve indicate that the company is still in its early growth phase, having been founded in 2021 in Belgium with a seed funding stage and a team of 11 employees (BounceWatch). The company's focus on health assessment through face analysis technology suggests a strategic emphasis on innovative health monitoring solutions, which aligns with current trends in health tech and AI-driven diagnostics (VentureRadar).

In terms of hiring patterns, there is no specific recent data on layoffs, but the company's growth trajectory and funding stage imply a cautious but ongoing hiring approach to support product development and market expansion. The broader industry context shows a cautious outlook for 2026, with a projected 1.6% increase in hiring compared to 2025, reflecting a stable but not booming job market (NACE).

Notably, the company's strategy appears aligned with the latest industry trends, such as the integration of AI in health diagnostics, which is expected to be a significant driver of growth in healthtech. The company's focus on contactless, smartphone-based health assessments positions it well within the expanding telemedicine and AI diagnostics sectors, signaling a strategic emphasis on innovative, scalable health solutions for the future (VentureRadar).

IntelliProve is a Belgian software startup specializing in health and wellbeing solutions through facial analysis technology. As of 2025, the company successfully secured €1.25 million in seed funding from notable investors including Miles Ahead, Wit-Gele Kruis, and imec.istart Fund, among others, demonstrating strong investor confidence and financial health (startuprise.co.uk).

The company's technology enables organizations to turn any camera-enabled device into a clinically validated health assessment tool, measuring vital health factors such as heart rate, breathing rate, and stress levels through facial scans (intelliprove.com). IntelliProve has also formed strategic collaborations, including a notable partnership with Neutraal Ziekenfonds Vlaanderen in Belgium, aimed at enhancing health insights and proactive health engagement for users (linkedin.com).

While specific revenue figures and detailed financial metrics are not publicly disclosed, the recent funding round and strategic partnerships indicate a positive financial trajectory and growth potential. The company operates across multiple European countries, including Belgium, the Netherlands, UK, Italy, France, Germany, and Denmark, further supporting its expanding market presence (tracxn.com). Overall, IntelliProve demonstrates a solid financial foundation with active fundraising, strategic collaborations, and a growing user engagement base.

IntelliProve actively participates in various industry events, conferences, and trade shows to showcase its innovative health technology solutions. Notably, they are involved in the Health and Wellbeing at Work 2026 event, where they exhibit their contactless health measurement tools and engage with industry professionals (healthwellbeingwork.co.uk). They also sponsor and attend the same event, providing opportunities for networking, demonstrations, and thought leadership in workplace health and safety, mental health, and stress management (healthwellbeingwork.co.uk).

Additionally, IntelliProve is known to participate in webinars and community-driven initiatives, such as the Workplace Wellbeing Roadshow in April 2024, where they presented their facial scanning technology and health insights solutions (videos). Their involvement in these events helps promote their AI-powered facial scanning technology for health assessment, which has garnered recognition, including winning the Belgian edition of the eAwards in 2022 (nttdata.com). Overall, IntelliProve maintains a strong presence in industry conferences, trade shows, and webinars focused on digital health, mental wellbeing, and innovative healthcare solutions.